Observing Real-World Weight Loss with Enavogliflozin in Type 2 Diabetes
There's a new study kicking off soon that wants to see how well enavogliflozin helps people with type 2 diabetes (T2D) lose weight. This drug has already shown promise in clinical settings, but doctors want to see how it works in real-world scenarios. The plan is to track over 1, 000 adults aged 19 to 80 with T2D and a high body mass index (BMI), who are taking or pl...